Eurocine Vaccines operates in the pharmaceutical industry with a focus on developing vaccines for the global market. The company develops vaccine candidates from early innovation and licenses them to partners for further development and commercialization. The activities are carried out in the bioscience cluster at Karolinska Institutet in Solna, Sweden.

Quotes for Eurocine Vaccines AB

Right Now

+/-
-0.0024
%
−12,12%
Latest
0.0174
High
0.0214
Low
0.0174
Volume
146 848
Turnover (SEK)
2 952
Market Value (MSEK)
3,3
Time (Latest trade)
2024-03-04 11:18

Board

CEO

  • Hans Arwidsson

Chairperson of the Board

  • Pierre Morgon

Board

  • Bengt Gustavsson
  • Hans Arwidsson
  • Jolanta Arwidsson
  • Pär Thuresson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 6,99 6,99 2023-12-27
Thomas Eldered 3,72 3,72 2024-02-08
Göran Bauge 3,71 3,71 2023-12-27
Nordnet Pensionsförsäkring 2,13 2,13 2023-12-27
Ken Brian Levicki 1,88 1,88 2023-12-27
Göran Erlandsson 1,67 1,67 2023-12-27
Mats Kenneth Pettersson 1,57 1,57 2023-12-27
Stig Brandt 1,57 1,57 2023-12-27
Johann Bech Vedsmand 1,57 1,57 2023-12-27
Ari Veli Juhani Korpela 1,52 1,52 2023-12-27
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream